Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
about
Deposition of fiber in the human nasal airwayDeposition of man-made fibers in a human nasal airwayFiber deposition pattern in two human respiratory tract replicasAerosol deposition in the extrathoracic regionThoracic fraction of inhaled fiber aerosolMechanisms of pharmaceutical aerosol deposition in the respiratory tractSystematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future DirectionsCFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro dataCharacterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airwaysTargeting aerosol deposition to and within the lung airways using excipient enhanced growthCharacterization of Nanoaerosol Size Change During Enhanced Condensational GrowthEvaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial modelMultimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.Numerical Model to Characterize the Size Increase of Combination Drug and Hygroscopic Excipient Nanoparticle AerosolsComparison of deposition in the USP and physical mouth-throat models with solid and liquid particlesIn silico models of aerosol delivery to the respiratory tract - development and applications.Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: comparison of CFD predictions with experimental resultsFeasibility of tissue plasminogen activator formulated for pulmonary delivery.Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.The use of computational fluid dynamics in inhaler design.Inhalation devices: from basic science to practical use, innovative vs generic products.Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.Development of the premature infant nose throat-model (PrINT-Model): an upper airway replica of a premature neonate for the study of aerosol delivery.Albuterol HFA for the management of obstructive airway disease.Aerosolized linear polyethylenimine-nitric oxide/nucleophile adduct attenuates endotoxin-induced lung injury in sheep.Inspiratory and expiratory aerosol deposition in the upper airway.Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.Balloon-based in vitro MDI aerosol deposition experiments on the effects of mouthpiece diameter.Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers.Simulated airflow and rigid fiber behavior in a realistic nasal airway modelOptimal Drug-Aerosol Delivery to Predetermined Lung SitesMicroparticle Transport and Deposition in the Human Oral Airway: Toward the Smart Spacer
P2860
Q23923592-97A222CF-DE78-4963-B6D2-128260F368E9Q23923593-9CE9A92B-FC4A-4A81-BF8E-99582B491D26Q23923594-8AF35A4D-477F-464F-98A3-3A4C67771548Q23924140-33FE6B83-B956-4450-BF60-CC9065ABE94DQ23924142-262DE1BE-EAA1-4595-AD38-09D144D99706Q23924144-FFD7AD8D-6899-44E5-AB56-028E416A56B3Q26769743-D42B16E2-5E14-4025-B16B-0AB5A4351CD9Q28383212-DC0ED1B3-42AA-4BF6-8AB9-B8A1FD9033B9Q28386376-C78984DE-680B-49C8-9245-95F1314FFFE4Q28390979-9A9025B0-55F7-4909-951F-E825C9542700Q28396996-04C7144E-5032-469A-9825-E05BF7221A7BQ28397573-D54F4A4A-AA1C-4E8A-9F11-2891997CE075Q33195090-6AF24247-4263-4543-A1CB-EF7860EAE7F6Q35127772-E44243DA-98EB-49F7-9EF4-E04EE425A778Q35590113-29A1C735-1853-4446-B8CE-8107846346CEQ35673202-70A42119-B265-42DC-90DE-FC908488B937Q35784530-47FDDBDB-00DC-46AB-BBDE-D1904CD6351EQ36088869-AEA9C746-12EF-4EE4-8D8A-2D54DB31FF49Q36165365-4FC2A0BC-5F54-4C46-8E79-14C7B25A2E72Q38071652-10BA9C20-20C5-4A72-B5C2-2599E90A961EQ38856654-D3FCFF00-5F64-485A-98B4-6A6D5FF2D4EEQ38981185-AC04233E-F459-43D0-932F-63218C1C3065Q40106044-B0D1501A-27E5-41D0-AEE3-0A77A215D7B9Q43061655-EC1033FF-51BC-4466-A8F8-5099233BD797Q43503013-1E78F7EA-7BF0-4DE6-B6B4-C19A8B028F72Q45530405-EA09C213-F079-4AE3-BA4C-0AA83E805920Q47272328-589D3DD2-59C1-4085-8939-BCA477E139C6Q50736432-92F02B61-4ACB-45A7-B4CC-DAD3C93D6D8DQ51006265-0F34E418-A730-476F-847A-BA04ACECB84FQ55111600-157787E9-E2FA-4E63-9D4C-8D16FCD5BA9BQ57183937-85CD6944-A4B2-4C46-A34C-C770061D32D5Q57437852-905BE11D-ECCD-4280-A108-204D04DEC12EQ58095240-396CEC81-1C1D-458F-9231-734C1AABE706
P2860
Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Respiratory deposition pattern ...... ons in a human airway replica.
@en
Respiratory deposition pattern ...... ons in a human airway replica.
@nl
type
label
Respiratory deposition pattern ...... ons in a human airway replica.
@en
Respiratory deposition pattern ...... ons in a human airway replica.
@nl
prefLabel
Respiratory deposition pattern ...... ons in a human airway replica.
@en
Respiratory deposition pattern ...... ons in a human airway replica.
@nl
P2093
P1476
Respiratory deposition pattern ...... ons in a human airway replica.
@en
P2093
P304
P356
10.1089/08942680152484180
P577
2001-01-01T00:00:00Z